STOCK TITAN
  1. Home
  2. Financials
  3. LSBCF
  4. Debt & Cash

LakeShore Biopharma Co (LSBCF) Debt by Year

LSBCF

LakeShore Biopharma Co carried $3.3M in long-term debt against $15.0M in cash and equivalents at the end of fiscal year 2025. Long-term debt fell 76.5% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters LakeShore Biopharma Co has filed alongside them.

FY2025 annual
Long-Term Debt $3.3M
Cash & Equivalents $15.0M
YoY -76.5%
Source SEC Filings Latest period FY2025, ended Mar 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LSBCF Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25FilingFY24FilingFY23FilingFY22FilingFY21Filing
Long-Term Debt$3.3M-76.5%$14.0M-67.4%$42.8M+6.7%$40.1MN/A
Cash & Equivalents$15.0M-56.9%$34.7M-35.5%$53.9M+26.1%$42.8M-28.2%$59.6M

LSBCF Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'25FilingQ4'24FilingQ4'23FilingQ4'22Filing
Long-Term Debt$3.3M-76.5%$14.0M-67.4%$42.8M+6.7%$40.1M
Cash & Equivalents$15.0M-56.9%$34.7M-35.5%$53.9M+26.1%$42.8M

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More LakeShore Biopharma Co financials

Frequently Asked Questions

LakeShore Biopharma Co carried $3.3M in long-term debt against $15.0M in cash and equivalents at the end of fiscal year 2025.

LakeShore Biopharma Co (LSBCF) long-term debt fell by 76.5% year over year, from $14.0M to $3.3M in fiscal year 2025.

LakeShore Biopharma Co (LSBCF) reported $3.3M in long-term debt in Q4 2025. This represents a decrease of 76.5% from the same quarter a year earlier.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what LakeShore Biopharma Co (LSBCF) reported on that line in every period on record.